Real-World Administration of Once-Daily MeltDose<sup>®</sup> Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
The calcineurin inhibitor tacrolimus is included in most immunosuppressive protocols after liver transplantation. This retrospective, observational 24-month study investigated the tolerability of once-daily MeltDose<sup>®</sup> prolonged-release tacrolimus (LCPT) after switching from twi...
Main Authors: | Katharina Willuweit, Alexandra Frey, Anne Hörster, Fuat Saner, Kerstin Herzer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/1/124 |
Similar Items
-
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01) -
Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
by: Gantar K, et al.
Published: (2020-09-01) -
Conversion from Twice-Daily to Once-Daily Tacrolimus Improves Graft Function but has no Influence on Proteinuria in Renal Transplant Recipients
by: Basic-Jukic Nikolina, et al.
Published: (2016-12-01) -
Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01) -
Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)